Evidence map›Paper›PMID 41203231›Full record

Trial reportJAMA network open2025

Participant Experiences in a Kidney Failure Care Intervention in the Navigate-Kidney Study.

Katherine Rizzolo, Julie Ressalam, Kayla Robledo, Elizabeth Juarez-Colunga, Neil R Powe, Jennifer E Flythe, Russell E Glasgow, Spero M Manson, Romana Hasnain-Wynia, Michel Chonchol and 9 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Katherine RizzoloBoston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Section of Nephrology, Boston, Massachusetts.
Julie RessalamDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora.
Kayla RobledoDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora.
Elizabeth Juarez-ColungaDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora.
Neil R PoweDepartment of Medicine, Priscilla Chan and Mark Zuckerberg San Francisco General Hospital, San Francisco, California.
Jennifer E FlytheDivision of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill.
Russell E GlasgowDepartment of Family Medicine and ACCORDS Dissemination and Implementation Science Program, University of Colorado Anschutz Medical Campus, Aurora.
Spero M MansonCenters for American Indian and Alaska Native Health, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora.
Romana Hasnain-WyniaDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora.
Michel ChoncholDepartment of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora.
Seth FurgesonDepartment of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora.
Allison JaureSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Chiadi E NdumeleDivision of Cardiology, Department of Medicine, John Hopkins University School of Medicine, Baltimore, Maryland.
Claudia CamachoDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora.
Daniel CukorDepartments of Medicine and Psychiatry, NYU Grossman School of Medicine, New York, New York.
Ladan GolestanehDepartment of Medicine, Section of Nephrology, Yale School of Medicine, New Haven, Connecticut.
Delphine S TuotDivision of Nephrology, Zuckerberg San Francisco General Hospital, University of California, San Francisco, San Francisco.
Lauren McBethDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora.
Lilia CervantesDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Latino individuals with dialysis-dependent kidney failure experience social challenges that render self-management of kidney disease difficult. In the Navigate-Kidney trial, a community health worker (CHW) intervention for Latinos receiving dialysis, intervention recipients experienced a decrease in interdialytic weight gain, a surrogate end point for patient self-management. Understanding how the Navigate-Kidney trial was experienced by participants is important when considering scalability and sustainment of the intervention. Objective: To examine participant perspectives on their experience in the Navigate-Kidney intervention. Design, Setting, and Participants: This qualitative study used semistructured interviews with participants receiving the Navigate-Kidney intervention. Participants received care at dialysis centers in Denver, Colorado, between November 2020 and August 2022 and were randomized to receive the Navigate-Kidney intervention. Interview transcripts were deidentified and analyzed using deductive thematic analysis. Data were examined from September 2024 to July 2025. Main Outcomes and Measures: The main outcomes were the themes and subthemes from the interviews. Results: Twenty-four Latino individuals (11 females [46%]; 13 males [54%]; mean [SD] age of 56 [11] years) participated. The identified themes and subthemes were (1) build trust through understanding health experience (cultivating a personalized connection, promoting optimism and resilience, demonstrating consistency and reliability); (2) address multilevel social and structural challenges to facilitate health system navigation (addressing health insurance barriers, improving food security, relieving the stress of administrative and financial tasks, bridging registered dietitian guidance, enabling attendance of and adherence to dialysis sessions and appointments, coordinating nonnephrology clinical care); (3) provide patient-centered education (improving language concordant communication, promoting health and numeracy literacy, providing culturally responsive dietary restriction); and (4) enhance self-management (exploring opportunities for transplant and peritoneal dialysis, facilitating quality of dialysis care and symptom management, encouraging medication adherence, increasing confidence in diet and fluid intake self-management, achieving clinical parameter targets, activating patients). Conclusions and Relevance: In this qualitative study of participants in the Navigate-Kidney trial, participants' experience with CHWs built trusting relationships through empathy and consistent support, helped them navigate complex health and social systems, provided culturally and linguistically tailored education, and empowered them to manage their care. Understanding participant perspectives about those activities that promoted health and well-being is critical for future patient-centered adaptations of Navigate-Kidney and similar interventions.

Indexed as

Hispanic or LatinoKidney Failure, ChronicPatient NavigationRenal DialysisRenal InsufficiencySelf-ManagementAdultAgedColoradoCommunity Health WorkersFemaleHumansMaleMiddle AgedQualitative Research

Identifiers

PMID41203231
PMCPMC12595532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.